Data / Form D filings / Virion Therapeutics, LLC
Virion Therapeutics, LLC: Form D filings
Virion Therapeutics, LLC, a biotechnology company in Newark, DE, filed 25 Form D notices with the SEC between 2018 and 2021. The latest, on October 7, 2021, reports $5.7 million sold of a $6 million offering to 49 investors.
Find out what Virion Therapeutics, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7 CREEK BEND COURT, Newark, DE, 19711
- Phone
- (800) 841-9303
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2018
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1746726
The full lists. Form D filings in Delaware: 1,342 rows, $67.10, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 7, 2021 | Amendment | $6,000,000 | $5,669,858 | $330,142 | 49 | Oct 28, 2019 | sec.gov |
| Aug 25, 2021 | Amendment | $6,000,000 | $3,880,858 | $2,119,142 | 40 | Oct 28, 2019 | sec.gov |
| Aug 11, 2021 | Amendment | $6,000,000 | $3,380,858 | $2,619,142 | 37 | Oct 28, 2019 | sec.gov |
| Jun 8, 2021 | Amendment | $6,000,000 | $3,060,858 | $2,939,142 | 34 | Oct 28, 2019 | sec.gov |
| May 13, 2021 | Amendment | $6,000,000 | $2,955,858 | $3,044,142 | 33 | Oct 28, 2019 | sec.gov |
| Mar 12, 2021 | Amendment | $6,000,000 | $2,825,858 | $3,174,142 | 32 | Oct 28, 2019 | sec.gov |
| Feb 24, 2021 | Amendment | $6,000,000 | $1,913,358 | $4,086,642 | 31 | Oct 28, 2019 | sec.gov |
| Jan 21, 2021 | Amendment | $6,000,000 | $1,238,333 | $4,761,667 | 25 | Oct 28, 2019 | sec.gov |
| Jan 4, 2021 | Amendment | $6,000,000 | $1,125,000 | $4,875,000 | 22 | Oct 28, 2019 | sec.gov |
| Nov 5, 2020 | Amendment | $6,000,000 | $1,295,000 | $4,705,000 | 23 | Oct 28, 2019 | sec.gov |
| Oct 20, 2020 | Amendment | $6,000,000 | $1,095,000 | $4,905,000 | 20 | Oct 28, 2019 | sec.gov |
| Sep 17, 2020 | Amendment | $6,000,000 | $960,000 | $5,040,000 | 16 | Oct 28, 2019 | sec.gov |
| Aug 13, 2020 | Amendment | $6,000,000 | $695,000 | $5,305,000 | 9 | Oct 28, 2019 | sec.gov |
| Jul 28, 2020 | Amendment | $6,000,000 | $595,000 | $5,405,000 | 8 | Oct 28, 2019 | sec.gov |
| May 20, 2020 | Amendment | $6,000,000 | $545,000 | $5,455,000 | 7 | Oct 28, 2019 | sec.gov |
| Mar 18, 2020 | Amendment | $6,000,000 | $695,000 | $5,305,000 | 11 | Oct 28, 2019 | sec.gov |
| Jan 6, 2020 | Amendment | $6,000,000 | $495,000 | $5,505,000 | 7 | Oct 28, 2019 | sec.gov |
| Nov 4, 2019 | New notice | $6,000,000 | $250,000 | $5,750,000 | 4 | Oct 28, 2019 | sec.gov |
| Nov 27, 2018 | Amendment | $5,500,000 | $5,231,402 | $268,598 | 80 | Jun 28, 2018 | sec.gov |
| Oct 9, 2018 | Amendment | $5,500,000 | $5,156,402 | $343,598 | 78 | Jun 28, 2018 | sec.gov |
| Sep 21, 2018 | Amendment | $5,500,000 | $4,851,402 | $648,598 | 78 | Jun 28, 2018 | sec.gov |
| Sep 4, 2018 | Amendment | $5,500,000 | $4,051,402 | $1,448,598 | 70 | Jun 28, 2018 | sec.gov |
| Aug 2, 2018 | Amendment | $5,500,000 | $3,736,402 | $1,763,598 | 65 | Jun 28, 2018 | sec.gov |
| Jul 24, 2018 | Amendment | $5,500,000 | $2,118,902 | $3,381,098 | 35 | Jun 28, 2018 | sec.gov |
| Jul 19, 2018 | New notice | $5,500,000 | $2,118,902 | $3,381,098 | 35 | Jun 28, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew Luber | Executive Officer, Director | |
| Bernard Rudnick | Executive Officer, Director |
Other biotechnology companies in Delaware that filed recently
- TCM Life Science Inc. $16,666 · Oct 26, 2026
- Amplica Bio, Inc. $30,000 · Sep 11, 2026
Every Form D from the week of Oct 4, 2021 · All recent filings in Delaware · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Virion Therapeutics, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.